Underwriting Agreements in the Life Sciences Tools & Services Industry
178 Contracts & Agreements
- 10x Genomics, Inc. (2 contracts)
- AbCellera Biologics Inc. (1)
- AbSci Corp (2)
- Adaptive Biotechnologies Corp (3)
- Agilent Technologies Inc (8)
- Akoya Biosciences, Inc. (2)
- Alpha Teknova, Inc. (1)
- ARQULE INC (2)
- ARYA Sciences Acquisition Corp III (2)
- Avantor, Inc. (7)
- Berkeley Lights, Inc. (2)
- Bio-Rad Laboratories (2)
- BIOANALYTICAL SYSTEMS INC (2)
- BioNano Genomics, Inc (7)
- BRUKER CORP (2)
- CM Life Sciences II Inc. (2)
- Codex DNA, Inc. (1)
- CODEXIS INC (4)
- Cytek BioSciences, Inc. (1)
- FLUIDIGM CORP (3)
- HighCape Capital Acquisition Corp. (3)
- Illumina Inc (5)
- IQVIA Holdings Inc. (11)
- IsoPlexis Corp (2)
- Lifesci Acquisition II Corp. (2)
- MARAVAI LIFESCIENCES HOLDINGS, INC. (4)
- Medpace Holdings, Inc. (6)
- Miromatrix Medical Inc. (2)
- NanoString Technologies Inc (5)
- NEOGENOMICS INC (8)
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (6)
- PerkinElmer (5)
- Personalis, Inc. (3)
- PPD, Inc. (2)
- PRA Health Sciences (7)
- Quanterix Corp (4)
- RAPID MICRO BIOSYSTEMS, INC. (1)
- Repligen Corporation (6)
- Seer, Inc. (2)
- SeqLL, Inc. (6)
- Singular Genomics Systems, Inc. (1)
- Sotera Health Co (4)
- Syneos Health (8)
- Thermo Fisher Scientific (17)
- VG Acquisition Corp. (2)
- Underwriting Agreement, dated as of December (BIOANALYTICAL SYSTEMS INC, Filed With SEC on December 18, 2024)
- Underwriting Agreement, dated September 4, 2024, between the Company and J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC, as representatives of the several underwriters... (Illumina Inc, Filed With SEC on September 9, 2024)
- Underwriting Agreement, dated September 4, 2024, among the Company, Citigroup Global Markets Inc., as underwriter, and the selling stockholders named in Schedule 2 thereto (Sotera Health Co, Filed With SEC on September 6, 2024)
- Underwriting Agreement, dated September 4, 2024, by and among the Company, BofA Securities, Inc., J.P. Morgan Securities LLC, Mizuho Securities USA LLC and Wells Fargo Securities,... (Agilent Technologies Inc, Filed With SEC on September 5, 2024)
- Underwriting Agreement, dated May 29, 2024, by and among Bruker Corporation and BofA Securities, Inc. and J.P. Morgan Securities LLC (BRUKER CORP, Filed With SEC on May 31, 2024)
- Underwriting Agreement, dated February 28, 2024, among the Company, J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, Citigroup Global Markets Inc., and Jefferies LLC, as... (Sotera Health Co, Filed With SEC on March 4, 2024)
- Underwriting Agreement dated February 27, 2024 (AbSci Corp, Filed With SEC on February 28, 2024)
- Underwriting Agreement, dated November 28, 2023, among the Company, as issuer, and BofA Securities, Inc., Morgan Stanley & Co. LLC, U.S. Bancorp Investments, Inc. and Wells Fargo... (Thermo Fisher Scientific, Filed With SEC on December 5, 2023)
- Form of Underwriting Agreement (SeqLL, Inc., Filed With SEC on November 7, 2023)
- Form of Underwriting Agreement (SeqLL, Inc., Filed With SEC on October 18, 2023)
- Form of Underwriting Agreement (SeqLL, Inc., Filed With SEC on August 15, 2023)
- Underwriting Agreement, dated August 7, 2023, among the Company, as issuer, and BNP Paribas Securities Corp., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC and Mizuho... (Thermo Fisher Scientific, Filed With SEC on August 10, 2023)
- Underwriting Agreement, dated as of June 7, 2023 among Akoya Biosciences, Inc., Morgan Stanley & Co. LLC and Piper Sandler & Co (Akoya Biosciences, Inc., Filed With SEC on June 12, 2023)
- Underwriting Agreement, dated as of March 7, 2023, by and between the Company and Piper Sandler & Co., as representative of the underwriters (Miromatrix Medical Inc., Filed With SEC on March 8, 2023)
- Underwriting Agreement, dated as of January 24, 2023 by and among Pacific Biosciences of California, Inc. and Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, and Cowen and... (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on January 27, 2023)
- Underwriting Agreement, dated November 29, 2022, between the Company and Goldman Sachs & Co. LLC and Citigroup Global Markets Inc., as representatives of the several underwriters... (Illumina Inc, Filed With SEC on December 13, 2022)
- Underwriting Agreement, dated November 14, 2022, among the Company, as issuer, and BofA Securities, Inc., Citigroup Global Markets Inc. and Deutsche Bank Securities Inc., as... (Thermo Fisher Scientific, Filed With SEC on November 21, 2022)
- Underwriting Agreement, dated November 14, 2022, among the Company, as issuer, and Citigroup Global Markets Limited, Deutsche Bank AG, London Branch and Merrill Lynch... (Thermo Fisher Scientific, Filed With SEC on November 21, 2022)
- Underwriting Agreement, dated October 14, 2022, among the Company, as issuer, and Citigroup Global Markets Limited, Mizuho Securities USA LLC, MUFG Securities EMEA plc and SMBC... (Thermo Fisher Scientific, Filed With SEC on October 20, 2022)
- Underwriting Agreement, dated as of February 23, by and among Bio-Rad Laboratories, Inc. and Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, and J.P. Morgan Securities LLC... (Bio-Rad Laboratories, Filed With SEC on March 2, 2022)
- Underwriting Agreement, dated November 9, 2021, among Thermo Fisher International, as issuer, the Company, as parent guarantor, Barclays Bank PLC, Morgan Stanley Europe SE, BofA... (Thermo Fisher Scientific, Filed With SEC on November 18, 2021)
- Underwriting Agreement, dated October 19, 2021, among the Company, as issuer, and Barclays Capital Inc., Morgan Stanley & Co. LLC, BofA Securities, Inc., Citigroup Global Markets... (Thermo Fisher Scientific, Filed With SEC on October 22, 2021)
- Underwriting Agreement, dated October 6, 2021, among Thermo Fisher International, as issuer, the Company, as parent guarantor, Barclays Bank PLC, Morgan Stanley Europe SE, BofA... (Thermo Fisher Scientific, Filed With SEC on October 18, 2021)
- Underwriting Agreement, dated October 7, 2021, by and among IsoPlexis Corporation and Morgan Stanley & Co. LLC, Cowen and Company, LLC, Evercore Group, L.L.C. and SVB Leerink LLC,... (IsoPlexis Corp, Filed With SEC on October 13, 2021)
- Form of Underwriting Agreement (IsoPlexis Corp, Filed With SEC on September 23, 2021)
- Underwriting Agreement, dated September 13, 2021, by and among Avantor, Inc. and Goldman Sachs & Co. LLC, Citigroup Global Markets Inc. and BofA Securities, Inc., as... (Avantor, Inc., Filed With SEC on September 16, 2021)
- Underwriting Agreement, dated September 8, 2021, by and among the Company and Goldman Sachs & Co. LLC, BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo... (PerkinElmer, Filed With SEC on September 10, 2021)
- Form of Underwriting Agreement (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on September 7, 2021)
- Underwriting Agreement, dated August 25, 2021 by and between SeqLL Inc. and Maxim Group LLC,, as representative of the underwriters named therein (SeqLL, Inc., Filed With SEC on August 31, 2021)
- Underwriting Agreement, dated August 9, 2021, among the Company, as issuer, and Barclays Capital Inc., Morgan Stanley & Co. LLC, BofA Securities, Inc. and Citigroup Global Markets... (Thermo Fisher Scientific, Filed With SEC on August 23, 2021)
- Form of Underwriting Agreement (Cytek BioSciences, Inc., Filed With SEC on July 19, 2021)
- Form of Underwriting Agreement (AbSci Corp, Filed With SEC on July 15, 2021)
- Form of Underwriting Agreement (RAPID MICRO BIOSYSTEMS, INC., Filed With SEC on July 12, 2021)
- Form of Underwriting Agreement (Alpha Teknova, Inc., Filed With SEC on June 21, 2021)
- Form of Underwriting Agreement (Codex DNA, Inc., Filed With SEC on June 14, 2021)
- Form of Underwriting Agreement (Miromatrix Medical Inc., Filed With SEC on June 10, 2021)
- Underwriting Agreement, dated June 2, 2021, by and among Syneos Health, Inc., the selling stockholders named therein and BofA Securities, Inc (Syneos Health, Filed With SEC on June 4, 2021)
- Form of Underwriting Agreement (SeqLL, Inc., Filed With SEC on May 28, 2021)
- Form of Underwriting Agreement (Singular Genomics Systems, Inc., Filed With SEC on May 24, 2021)
- Underwriting Agreement, dated May 3, 2021, by and among Syneos Health, Inc., the selling stockholders named therein and BofA Securities, Inc (Syneos Health, Filed With SEC on May 5, 2021)